Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms

Specific PHGKB|Cancer|PHGKB

Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Jan 06, 2019

---

• https://www.cancer.gov/news-events/cancer-currents-blog/2019/early-stage-lung-cancer-biomarker  
  NCI, January 3, 2019
• Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms  
  G Riedlinger et al, JAMA Oncology, January 3, 2019
• Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA  
  M Gao et al, Genome Medicine, January 4, 2019
• The Race to Diagnose Cancer With a Simple Blood Test-Liquid biopsies could transform cancer care as we know it  
  R Winslow, Medium, January 3, 2019
• Immune Checkpoint Inhibitors  
  NCI Video, 2018
• [Expression and clinical significance of MMR protein and MLH1 promoter methylation testing in endometrial cancer].  
  Jin W et al. Zhonghua fu chan ke za zhi 2018 Dec 53(12) 823-830
• 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer.  
  Chen Xiang-Hong et al. Biomarkers in medicine 2018 Dec
• Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank.  
  Olson Janet E et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2018 Dec 2(4) 352-358
• BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.  
  Cline Melissa S et al. PLoS genetics 2018 Dec 14(12) e1007752
• Cancer communication research in the era of genomics and precision medicine: a scoping review.  
  Kaphingst Kimberly A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Dec